InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-27 · accession 0001225208-21-010897 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-27 2021-07-27 BSX Butcher Arthur C EVP, Pres, Asia Pacific M - OptEx $13.08 +4,250 35.4K +14% +$55.6K
D 2021-07-27 2021-07-27 BSX Butcher Arthur C EVP, Pres, Asia Pacific S - Sale+OE $4,500.00 -9,673 25.7K -27% -$43.53M
D 2021-07-27 2021-07-27 BSX Butcher Arthur C EVP, Pres, Asia Pacific M - OptEx $0.00 -4,250 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-27 M A 4,250 $13.08 35,422 D — — (F2) Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
2 Common Common Stock 2021-07-27 S D 9,673 $4,500.00 25,749 D — — (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (Right to Buy) 2021-07-27 M D 4,250 $0.00 0 D $13.08 · — to 2024-02-24 4,250 Common Stock (F5) Grant to the reporting person of an option to purchase 17,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.